// App-Quantinova.ai

AB0341 (2021) : SLE PREGNANCIES AT HIGH RISK FOR PRE-ECLAMPSIA BENEFIT MOST FROM COMBINATION OF LOW DOSE ASPIRIN AND HYDROXYCHLOROQUINE

Researchers

Presenter

  • I. Haase

Principal Investigators

  • G. Chehab

  • O. Sander

  • M. Schneider

  • R. Fischer-Betz

Medical Centers

  • Heinrich Heine University Düsseldorf, Department of Rheumatology and Hiller Research Unit Rheumatology, Düsseldorf, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Nephrology

  • Cardiovascular (CVS)

  • Obstetrics/Gynecology

Disease

  • Lupus nephritis

  • Preeclampsia

  • Hypertension

  • Nephritis

  • Lupus

Biomarkers

  • Body mass index

Drug/Treatment

  • Hydroxychloroquine

  • Aspirin

  • Albyl-E

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A